Sharda Cropchem's Q4 and FY26 results reveal an emphasis on their asset-light strategy, global reach, and expansion through increased registrations and distribution networks.

Sharda Cropchem achieves a new high in FY26 with revenue reaching ₹5,268 crore, marking a 22% increase. The company aims for a further growth of 10-15% in FY27.

Sharda Cropchem reported a total income of INR 5373 crores and a net profit of INR 681 crores for FY26, leading to a dividend declaration of INR 9 per share. The results reflect the company's successful global operations in the agrochemical sector.

Sharda Cropchem reported a 13% increase in Q4 revenue, reaching INR 20.6 billion compared to the previous year, signaling positive growth trends for the company.

Sharda Cropchem's Q4 earnings skyrocketed by 57%, reaching INR 318.6 crore, while revenues increased by 13% to INR 2065 crore. The company's EBITDA surged by 61%, with an improved margin of 23.6%. This substantial growth indicates a promising financial performance for Sharda Cropchem.

Foreign Institutional Investors (FIIs) have shown a preference for small-cap stocks despite offloading ₹1.12T of Indian equities in March 2026, with notable investments in Shringar House of Mangalsutra, Granules India, Repco Home Finance, and Sharda Cropchem. The focus is driven by Shringar's projected 30% growth, Granules' new product launches, Repco's IT upgrades, and Sharda's robust global agrochemical market presence.

Sharda Cropchem's improved performance has resulted in a shift from a "very attractive" to an "attractive" valuation, according to analysts. This revised assessment considers the company's current performance in relation to historical averages and industry peers.

Sharda Cropchem experienced a significant increase after Dolly Khanna purchased a 1.09% stake in March 2026, marking her absence in the previous quarter. The company's Q3 FY25 net profit saw an impressive surge of 366%, reaching Rs 145.1 crore. Forecasts predict a revenue growth of 15-20% for FY27.

Sharda Cropchem reports no disruption to its operations due to the ongoing West Asia conflict. The company has successfully transferred any tariff increases to customers, maintaining its trajectory towards meeting FY26 targets.

Sharda Cropchem, an agrochemical exporter based in Mumbai, has experienced significant growth over the past year, with its stock price surging by approximately 90%. This remarkable increase has more than tripled investors' wealth over a five-year period. The company currently holds a market capitalization of around ₹8,200 crore.